The presence of the CD133/ERK/SRC signaling axis indicates that CD133 acts as a characteristic mesenchymal regulator and is a “functional” marker of migration, invasion, and metastasis in pancreatic cancer. This evidence concerns the gene PROM1 and familial pancreatic carcinoma.